Top

Clinical Rheumatology

Published in:

01-09-2020 | Systemic Lupus Erythematosus | Letter to the Editor

Comment on “Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases”

Authors: Shu-Shan Zhao, Wei-Min Li

Published in: Clinical Rheumatology | Issue 9/2020

Excerpt

Dear Editor, …

Bao Y, Dong C, Ji J, Gu Z (2020) Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases. Clin Rheumatol. https://doi.org/10.1007/s10067-020-05170-9

De Luca F, Shoenfeld Y (2019) The microbiome in autoimmune diseases. Clin Exp Immunol 195(1):74–85. https://doi.org/10.1111/cei.13158CrossRefPubMed

Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, Spector TD, Clark AG, Ley RE (2014) Human genetics shape the gut microbiome. Cell 159(4):789–799. https://doi.org/10.1016/j.cell.2014.09.053CrossRefPubMedPubMedCentral

Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, Shilo S, Lador D, Vila AV, Zmora N, Pevsner-Fischer M, Israeli D, Kosower N, Malka G, Wolf BC, Avnit-Sagi T, Lotan-Pompan M, Weinberger A, Halpern Z, Carmi S, Fu J, Wijmenga C, Zhernakova A, Elinav E, Segal E (2018) Environment dominates over host genetics in shaping human gut microbiota. Nature 555(7695):210–215. https://doi.org/10.1038/nature25973CrossRef

Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, Nakhjavani MR, Mohtadi-Nia J (2014) Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis 17(5):519–527. https://doi.org/10.1111/1756-185X.12333CrossRefPubMed

Vaghef-Mehrabany E, Alipour B, Homayouni-Rad A, Sharif SK, Asghari-Jafarabadi M, Zavvari S (2014) Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 30(4):430–435. https://doi.org/10.1016/j.nut.2013.09.007CrossRefPubMed

Mandel DR, Eichas K, Holmes J (2010) Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med 10:1. https://doi.org/10.1186/1472-6882-10-1CrossRefPubMedPubMedCentral

Wang P, Tao JH, Pan HF (2016) Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis. Inflammopharmacology 24(5):189–196. https://doi.org/10.1007/s10787-016-0277-0CrossRefPubMed

Title: Comment on “Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases”
Authors: Shu-Shan Zhao
Wei-Min Li
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keywords: Systemic Lupus Erythematosus
Ankylosing Spondylitis
Respiratory Microbiota
Rheumatoid Arthritis
Published in: Clinical Rheumatology / Issue 9/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05295-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comment on “Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases”

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2020

Analysis of risk factors for complications and adverse obstetrical outcomes in women with Takayasu arteritis: a French retrospective study and literature review

Association between comorbidities and extraglandular manifestations in primary Sjögren’s syndrome: a multicenter cross-sectional study

A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome

FDG PET/CT used in identifying adult-onset Still’s disease in connective tissue diseases

Challenges in delivering rheumatology care during COVID-19 pandemic

Early onset primary Sjögren syndrome, clinical and laboratory characteristics

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page